眠尔通曾被认为是一种毒性较小的安定药,但近年来随着临床上的广泛应用,对它具有的不良反应已有新的认识,因此对眠尔通的安全性,有必要给以重新估价。眠尔通为丙二醇类化合物,是1950年被合成1954年开始在临床上应用的。共化学名为2甲基—2正丙基—1,3丙二醇二氨基甲酸酯,在结构上与巴比妥类(属于丙二酰脲化合物)及氯丙嗪(属于吩噻嗪衍化物)均完全不同。眠尔通是中枢神经系统安定药,可选择 Mellon was considered to be a less toxic stabilizer, but in recent years with the clinical application, it has adverse reactions have been new understanding, so the safety of Mellon, it is necessary Give a revaluation. Mellon is a propylene glycol compounds, was synthesized in 1950, 1954 clinical application. The common chemical name is 2-methyl-2-n-propyl-1,3-propanediol dicarbamate, structurally related to barbiturates (belonging to the malonyl urea compound) and chlorpromazine ) Are completely different. Mellon is the central nervous system stabilizer, optional